Volume : 12, Issue : 08, August- 2025
Title:
DESIGN AND DEVELOPMENT OF ORAL FLOATABLE IN-SITU GEL FOR INVASIVE FUNGAL INFECTION
Authors :
* Vazir Ashfaq Ahmed, Pooja H V, Mishba Nikhath, Sanjana S
Abstract :
In the present study in-situ oral floatable gelling system of Posaconazole was successfully formulated by using different concentrations of gellan gum and pectin. Total eleven formulations were prepared with variable concentration of gellan gum and pectin After performing the evaluation tests of prepared formulations, it can be summarized that Batch F9 was selected as best formulation, because it shows good release property of drug from the gel, having sufficient gel strength, shows optimum pH required for sol-gel conversion, and it also exhibit the acceptable result of other parameters. The release pattern of the optimized formulation (F9) was best fitted to a first order. The mechanism of the drug release was non-Fickian (super case II) transport. Non-Fickian (super case II) transport mechanism for releasing a drug associated with stresses and state-transition in hydrophilic glassy polymers, which swell in water or biological fluids. This term also includes polymer disentanglement and erosion. In-situ forming polymeric formulations drug delivery system is in a sol form before administration in the body, but once administered, it undergoes gelation in-situ to form a gel. The findings showed that the oral floatable in-situ gel offers a better sustained property compared to a conventional dosage form.
Keywords: Posaconazole, gellan gum, oral floatable gelling system.
Cite This Article:
Please cite this article in press Vazir Ashfaq Ahmed et al ., Design And Development Of Oral Floatable In-Situ Gel For Invasive Fungal Infection., Indo Am. J. P. Sci, 2025; 12(08).
Number of Downloads : 10
References:
1. Patil SG, Shahi SR, Dandale JJ. In-situ gel: a gastro-retentive drug delivery system, Int J Pharm Sci. 2025;3(1):278-93.
2. Rajdeep Gupta, Ragini Singh Bundela “Formulation and evaluation of gastroretentive in situ gelling system of saxagliptin”. Curr Res Pharma Sci 2025;15(1): 8-13.
3. Puri G. Ashutosh, Sandeep C et al.Formulation and evaluation of in-situ gel for periodontal disease. Asian J Pharma Res Devel.2025;13(3): 48–58
4. Firacative C. Invasive fungal disease in humans: are we aware of the real impact Mem Inst Oswaldo Cruz, Rio de Janeiro 2020; (115): e200430
5. Ravikant, Kaur T,Gupte S, et al. A review on emerging fungal infections and their significance J Bacteriol Mycol 2015;1(2):39‒41
6. Ramana KV, Kandi S, Kumar VB. Invasive fungal infections: a comprehensive review Am J Infect Dis Microbiol 2013;1(4):64-9
7. Lai CC, Tan CK. Current challenges in the management of invasive fungal infections J Infect Chemother 2008; 14:77–85
8. Collins CD, Smith JA, Kaul DR. Prophylaxis of invasive fungal infections: a review of the use of posaconazole. Clin Med Ther 2009; 1:1399–408
9. Page AV, Liles WC. Posaconazole: A new agent for the prevention and management of severe, refractory or invasive fungal infections. Can J Infect Dis Med Microbiol 2008;19(4):297-305.
10. Rathod H, Patel V, Moin M, In-situ gel as a novel approach of gastro retentive drug delivery. IJPLS 2010; 1(8):440-447
11. Pandya K, Agrawal , Dashora A, et al. Formulation and evaluation of oral floatable in-situ gel of ranitidine hydrochloride. J Drug Del & Therapeutics 2013; 3(3): 90-97
12. Wamorkar V, Varma MM, Manjunath SY, Formulation and evaluation of stomach specific in-situ gel of metoclopramide using natural, bio-Degradable polymers. Int J Res Pharm Biomedical Sci 2011; 2(1): 193-201.
13. Badgujar SD, Sontakke MA, Narute DR, et al. Formulation and evaluation of sumatriptan succinate nasal in-situ gel using fulvic acid as novel permeation enhancer. Int J Pharm. Res. and Dev. 2010; 2(8): 47-52
14. Vora V, Basu B, Formulation and characterization of novel floating in-situ gelling system for controlled delivery of ramipril. Int J Drug Del 2013; 5: 43-55.
15. Thomas LM. Formulation and evaluation of floating oral in-situ gel of metronidazole. Int J Pharm Pharm Sci 6(10): 265-269
16. Panwar AS, Sharma M, Formulation and evaluation of floating stomach specific in-situ gel of nizatidine. Int J Pharm & Biological Archives 2014; 5(1): 115–123.
17. Xu H, Shi M, Liu Y, Jiang J, Ma T. A novel in situ gel formulation of ranitidine for oral sustained delivery. Biomol Ther 2014 22(2):161-5.